Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alector, Inc. - Common Stock (NQ:ALEC)

1.510 +0.010 (+0.67%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alector, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Via Benzinga
Expert Ratings for Alector
Within the last quarter, Alector (NASDAQ:ALEC) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
Upgrades 
Via Benzinga
Alector: Q4 Earnings Insights
Alector (NASDAQ:ALEC) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
Upgrades 
Via Benzinga
R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development
Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia... 
Via FinancialNewsMedia
Alector Highlights Mid-Stage Study Data On Lead Dementia Drug
Alector Inc (NASDAQ: ALEC) is flashing some AL001 (latozinemab) Phase 2 data at an Alzheimer’s and Parkinson’s disease conference, this time in dementia with a different type of mutation: C9orf72. 
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 100 Points; Gold Surges 2.5%
U.S. stocks traded higher toward the end of trading, with the Nasdaq adding 100 points on Tuesday. The Dow traded up 0.39% to 32,946.58 while the NASDAQ rose 0.78% to 12,931.15.... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results. Kala... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock rose 86.8% to $1.14 during Tuesday's regular session. The current volume of 2.6 million shares is 326.2% of Kala... 
Via Benzinga
Mid-Day Market Update: U.S. Stocks Turn Higher; Dow Jumps Over 400 Points
U.S. stocks turned higher midway through trading, with the Dow Jones climbing more than 400 points on Tuesday. The Dow traded up 1.28% to 33,236.65 while the NASDAQ rose 1.61% to... 
Via Benzinga
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers FibroGen (NASDAQ:FGEN) stock mov... 
Via Benzinga
60 Stocks Moving In Tuesday's Mid-Day Session
Gainers Enservco Corporation (NYSE: ENSV) surged 228% to $8.20 after jumping around 85% on Monday. Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 168% to $0.8850. Hycroft... 
Via Benzinga
Chief Executive Officer Of Alector Sold $2.77 Million In Stock
Arnon Rosenthal, Chief Executive Officer at Alector (NASDAQ:ALEC), made a large insider sell on September 23, according to a new SEC filing. What Happened: A Form 4 filing from... 
Via Benzinga
Topics Regulatory Compliance
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth... 
Via Benzinga
Why Alector Shares Are Diving Today
There has been a major shakeup in the C-suite. 
Via The Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop
Toward the end of trading Wednesday, the Dow traded down 0.24% to 35,015.62 while the NASDAQ fell 0.61% to 15,280.10. The S&P also fell, dropping 0.20% to 4,510.78. The U.S.... 
Via Benzinga
Topics Stocks
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Kadmon Holdings (NASDAQ:KDMN) shares increased by 72.64% to $9.15 during Wednesday's regular session. Trading volume for Kadmon Holdings's stock is 95.3... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday. Helbiz, Inc. (NASDAQ: HLBZ) gained 84% to... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 1%; REV Group Shares Plummet
Midway through trading Wednesday, the Dow traded down 0.45% to 34,942.88 while the NASDAQ fell 1.09% to 15,207.45. The S&P also fell, dropping 0.55% to 4,495.35. The U.S. has... 
Via Benzinga
Topics Stocks
30 Stocks Moving In Wednesday's Mid-Day Session
Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; Korn Ferry Reports Upbeat Q1 Results
Following the market opening Wednesday, the Dow traded up 0.03% to 35,111.48 while the NASDAQ fell 0.27% to 15,332.05. The S&P also fell, dropping 0.02% to 4,519.29. The U.S.... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers F-star Therapeutics (NASDAQ:FSTX... 
Via Benzinga
Alector Stock Falls After Flashing 12-Month Data From Mid-Stage Trial In Frontotemporal Dementia Patients
Alector Inc (NASDAQ: ALEC) detailed early data from its lead drug, AL001, INFRONT-2 Phase trial at the Alzheimer's Association International Conference (AAIC... 
Via Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
70 Biggest Movers From Yesterday
Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.